This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Belenje A, Reddy RU, Parmeswarappa DC, Padhi TR, Subbarao B, Jalali S. Evaluation of optical coherence tomography biomarkers to differentiate favourable and unfavourable responders to intravitreal anti-vascular endothelial growth factor treatment in retinopathy of prematurity. Eye (London) 2023. https://doi.org/10.1038/s41433-023-02824-1
Mangalesh S, McGeehan B, Tai V, Chen X, Tran-Viet D, Vajzovic L. Study of Eye Imaging in Preterm Infants Group et al. Macular OCT characteristics at 36 weeks’ postmenstrual age in infants examined for retinopathy of prematurity. Ophthalmol Retin. 2021;5:580–92.
Michalak SM, Mangalesh S, Chen Y, Shen LL, Tai V, Winter K. BabySTEPS Group et al. Longitudinal choroidal development in preterm infants. Ophthalmol Sci. 2023;4:100359.
Vinekar A, Avadhani K, Sivakumar M, Mahendradas P, Kurian M, Braganza S, et al. Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Investig Ophthalmol Vis Sci. 2011;52:5183–8.
Vinekar A, Nair AP, Sinha S, Vaidya T, Chakrabarty K, Shetty R, et al. Tear fluid angiogenic factors: potential noninvasive biomarkers for retinopathy of prematurity screening in preterm infants. Investig Ophthalmol Vis Sci. 2021;62:2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vinekar, A., Mangalesh, S. Optical coherence tomography biomarkers in preterm infants with and without retinopathy of prematurity: fallacies and facts. Eye (2024). https://doi.org/10.1038/s41433-024-03061-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-03061-w